Taysha Gene Therapies, Inc.

NasdaqGS:TSHA Stock Report

Market Cap: US$454.5m

Taysha Gene Therapies Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGS:TSHA Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
17 Nov 23BuyUS$163,000Paul ManningIndividual100,000US$1.63
16 Aug 23BuyUS$14,820,000Paul ManningIndividual16,466,667US$0.90
16 Aug 23BuyUS$100,000Phillip DonenbergIndividual111,111US$0.90
16 Aug 23BuyUS$400,000Sean NolanIndividual444,444US$0.90
16 Aug 23BuyUS$700,000Sean StalfortIndividual777,778US$0.90
13 Jul 23SellUS$60,771R. SessionIndividual85,872US$0.71
23 Jun 23SellUS$20,119R. SessionIndividual28,608US$0.70
21 Jun 23SellUS$307,844R. SessionIndividual434,615US$0.71
16 May 23BuyUS$3,400Sukumar NagendranIndividual5,000US$0.68

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of TSHA?
Owner TypeNumber of SharesOwnership Percentage
Private Companies2,8710.00154%
Public Companies7,266,3423.89%
General Public14,103,8817.54%
Hedge Funds16,893,1859.03%
VC/PE Firms28,885,37515.4%
Individual Insiders33,865,90118.1%
Institutions86,000,72046%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 191.4%.


Top Shareholders

Top 25 shareholders own 86.21% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
12.6%
Paul Manning
23,495,778US$57.1m0.43%no data
12%
FMR LLC
22,439,124US$54.5m-8.52%no data
9.88%
RA Capital Management, L.P.
18,472,503US$44.9m0%0.61%
9.03%
RTW Investments, LP
16,893,185US$41.1m0%0.72%
5.57%
VR Adviser, LLC
10,412,872US$25.3m-27.9%1.42%
4.82%
R. Session
9,012,837US$21.9m0%no data
3.89%
Astellas Pharma Inc.
7,266,342US$17.7m0%no data
3.31%
The Vanguard Group, Inc.
6,195,567US$15.1m16.3%no data
2.33%
Avoro Capital Advisors LLC
4,355,555US$10.6m11%0.15%
2.14%
Baker Bros. Advisors LP
4,004,756US$9.7m59.9%0.12%
2.02%
Eversept Partners, L.P.
3,780,714US$9.2m122%0.77%
1.98%
Tybourne Capital Management (HK) Ltd.
3,700,000US$9.0m147%1.32%
1.96%
Artal Group S.A.
3,663,104US$8.9m0%0.25%
1.92%
Acuta Capital Partners, LLC
3,589,333US$8.7m-6.23%5.93%
1.81%
Millennium Management LLC
3,380,532US$8.2m0%0.01%
1.56%
TCG Crossover Management, LLC
2,912,861US$7.1m-73.8%0.64%
1.46%
Point72 Asset Management, L.P.
2,736,434US$6.6m192%0.01%
1.44%
BlackRock, Inc.
2,699,238US$6.6m261%no data
1.35%
Polar Capital Holdings Plc
2,518,909US$6.1m-0.44%0.03%
1.23%
Citadel Advisors LLC
2,297,556US$5.6m0%0.01%
1.12%
Ghost Tree Capital, LLC
2,100,000US$5.1m58.5%3.22%
0.82%
Nolan Capital, Inc.
1,535,545US$3.7m0%no data
0.76%
Susquehanna International Group, LLP, Asset Management Arm
1,428,146US$3.5m605%0.01%
0.66%
T. Rowe Price Group, Inc.
1,227,333US$3.0m-1.61%no data
0.6%
Schonfeld Strategic Advisors LLC
1,119,375US$2.7m55.5%0.02%
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.